Literature DB >> 14761620

[A cross-sectional study on knowledge and the ability of hypertension treatment among physicians in district and community hospitals].

Wen-hua Wang1, Dong Zhao, Zhe-chun Zeng, Yan-na Jia, Ying Liu, Xiu-ping Zhu, Zhi-xiang Wang.   

Abstract

OBJECTIVE: To estimate the knowledge level and clinical ability of hypertension treatment among physicians in district and community hospitals in big and moderate cities.
METHODS: 43 district and community hospitals were selected by non-random sampling in Beijing and Baotou inner-Mongolia municipality. A total of 754 physicians in those hospitals were investigated, through an examination.
RESULTS: The correct rates on blood pressure stages, risk stratification and treatment strategy were 64%, 28% and 54%, respectively. The knowledge level on non-pharmacologic treatments was insufficient among physicians. The knowledge level of special indications on the common antihypertensive drugs (such as diuretics, beta-blockers, ACE inhibitors) was even worse.
CONCLUSION: Physicians in district and community hospitals did not have enough knowledge and ability to fulfill the task of hypertension treatment and management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14761620

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  2 in total

1.  Artificial neural network based model for cardiovascular risk stratification in hypertension.

Authors:  Gangmin Ning; Jie Su; Yingqi Li; Xiaoying Wang; Chenghong Li; Weimin Yan; Xiaoxiang Zheng
Journal:  Med Biol Eng Comput       Date:  2006-02-11       Impact factor: 2.602

2.  Provider competence in hypertension management and challenges of the rural primary healthcare system in Sichuan province, China: a study based on standardized clinical vignettes.

Authors:  Yuju Wu; Ruixue Ye; Qingzhi Wang; Chang Sun; Sha Meng; Sean Sylvia; Huan Zhou; Dimitris Friesen; Scott Rozelle
Journal:  BMC Health Serv Res       Date:  2022-07-01       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.